2018
DOI: 10.1186/s13073-018-0555-0
|View full text |Cite
|
Sign up to set email alerts
|

INSaFLU: an automated open web-based bioinformatics suite “from-reads” for influenza whole-genome-sequencing-based surveillance

Abstract: BackgroundA new era of flu surveillance has already started based on the genetic characterization and exploration of influenza virus evolution at whole-genome scale. Although this has been prioritized by national and international health authorities, the demanded technological transition to whole-genome sequencing (WGS)-based flu surveillance has been particularly delayed by the lack of bioinformatics infrastructures and/or expertise to deal with primary next-generation sequencing (NGS) data.ResultsWe develope… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
74
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 63 publications
(80 citation statements)
references
References 48 publications
(46 reference statements)
0
74
0
Order By: Relevance
“…'Data can also be used in innovative ways that bring economic benefits to citizens and businesses by releasing untapped enterprise and entrepreneurship' [8]. The leveraging of influenza virus (RNA) sequences [9] for the development of novel, more efficacious influenza vaccines [8] stands as one of a handful of clear-cut examples of the potential societal and economic benefits from Open Data. The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) also clearly demonstrates the synergy that can come from ensuring Open Access to sequencing data-bringing rapid insights that can stem the spread of a potentially pandemic virus in real time [10,11].…”
mentioning
confidence: 99%
“…'Data can also be used in innovative ways that bring economic benefits to citizens and businesses by releasing untapped enterprise and entrepreneurship' [8]. The leveraging of influenza virus (RNA) sequences [9] for the development of novel, more efficacious influenza vaccines [8] stands as one of a handful of clear-cut examples of the potential societal and economic benefits from Open Data. The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) also clearly demonstrates the synergy that can come from ensuring Open Access to sequencing data-bringing rapid insights that can stem the spread of a potentially pandemic virus in real time [10,11].…”
mentioning
confidence: 99%
“…Core bioinformatics analyses were conducted using INSaFLU (https://insaflu.insa.pt/), a webbased platform for amplicon-based NGS data analysis [44]. Briefly, the bioinformatics pipeline (detailed in Borges et al [44]) involved: i) raw NGS reads quality analysis and improvement Table. For the integration of mosquitos circulating in Portugal into the global Ae.…”
Section: Discussionmentioning
confidence: 99%
“…Core bioinformatics analyses were conducted using INSaFLU (https://insaflu.insa.pt/), a webbased platform for amplicon-based NGS data analysis [44]. Briefly, the bioinformatics pipeline (detailed in Borges et al [44]) involved: i) raw NGS reads quality analysis and improvement Table. For the integration of mosquitos circulating in Portugal into the global Ae. albopictus genetic diversity, nucleotide consensus sequences of both COI gene and mitogenome were aligned against multiple sequences available at GenBank (183 COI and 26 mitogenome sequences previously reported at worldwide level; S1 and S2 Tables respectively) using MAFFT v. 7.313 [46].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Responses to Ebola virus and Zika virus outbreaks, among others, have demonstrated an essential role of genomics in strategies for surveillance and management of infectious diseases. Discussing avian influenza, Lam and Pybus [ 8 ] forecast that successful epidemic control “on a global scale will require increased genomic surveillance in poorly characterized regions, timely data sharing, and the development of new analytical methods to test hypotheses concerning influenza virus emergence and transmission.” Toward this, Borges et al [ 9 ] have created INSaFLU, a bioinformatics platform for influenza virus sequencing data aimed toward increasing accessibility and analytical standardization across global research efforts. Such initiatives to maximize data and resource sharing to facilitate infectious disease research extend well beyond influenza—not only does the siRNA screening system presented by Hoenen and colleagues [ 5 ] provide the community with a minable dataset related to Ebola pathogenesis, but it also offers an experimental system that does not require biosafety level (BSL)-4, allowing similar experiments to be undertaken by many more labs.…”
mentioning
confidence: 99%